Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 625 of 1674 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/19/17
End: 03/19/18
Due: 03/19/19
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 03/25/24
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/25
Due: 01/31/26
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Phase: N/A
Priority: Normal
Start: 02/22/16
End: 07/17/22
Due: 07/17/23
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 03/06/20
Due: 03/06/21
Phase: N/A
Priority: Normal
Start: 10/01/17
End: 07/01/20
Due: 07/01/21
Phase: N/A
Priority: Normal
Start: 01/23/20
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 04/18/22
End: 11/30/28
Due: 11/30/29
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 11/06/19
End: 01/09/24
Due: 01/09/25
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 03/28/25
End: 11/30/29
Due: 11/30/30
Phase: N/A
Priority: Normal
Start: 06/20/18
End: 02/11/22
Due: 02/11/23
Phase: N/A
Priority: Normal
Start: 11/27/17
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 10/02/17
End: 03/23/21
Due: 03/23/22
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 02/22/19
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 02/01/14
End: 07/31/17
Due: 07/31/18